Cisplatin-resistant prostate cancer model: Differences in antioxidant system, apoptosis and cell cycle.
about
Oxidative Stress Resistance in Metastatic Prostate Cancer: Renewal by Self-EatingVitamin D derivatives enhance cytotoxic effects of H2O2 or cisplatin on human keratinocytesMultimodal holographic microscopy: distinction between apoptosis and oncosis.Cannabidiol rather than Cannabis sativa extracts inhibit cell growth and induce apoptosis in cervical cancer cells.Metallothionein 2A core promoter region genetic polymorphism and its impact on the risk, tumor behavior, and recurrences of sinonasal inverted papilloma (Schneiderian papilloma)Identifying therapeutic targets in gastric cancer: the current status and future directionThe timing of caffeic acid treatment with cisplatin determines sensitization or resistance of ovarian carcinoma cell lines.Genetic polymorphisms (rs10636 and rs28366003) in metallothionein 2A increase breast cancer risk in Chinese Han population.Biomarkers to assess the efficiency of treatment with platinum-based drugs: what can metallomics add?Effects of cisplatin on the LSD1-mediated invasion and metastasis of prostate cancer cells.KRAS NF-κB is involved in the development of zinc resistance and reduced curability in prostate cancer.Nedaplatin sensitization of cisplatin-resistant human non-small cell lung cancer cells.Cisplatin based therapy: the role of the mitogen activated protein kinase signaling pathway.
P2860
Q27334935-A5F60AD4-26D2-4991-8FA6-67ADBBDF7671Q28393501-AC29C895-0BE1-4C6C-8461-FDA5A578996EQ35585444-E34FEFFC-8CB6-4861-A49D-FFF36FBA0450Q36120780-DDD070F8-55C7-4556-B032-6FA67356A7E3Q36352771-3492A8CB-799D-46F0-A652-FB982B057435Q36398732-18BAD16B-C737-4BD2-8A0E-E83774A0B380Q37496947-52C63C5A-853D-476B-B2CE-E3C275CE554DQ37715508-4A4033FE-A81D-4A18-852B-8D73060290A1Q38267182-59BD472A-30F9-4C2A-BE64-B0CA028E8DF7Q38754205-E7E6C071-FB94-4CD8-B4BE-5C9F3333482BQ38985079-C89D65EB-1121-4BE0-BB7B-E2364286C719Q39644220-1946BD0D-70EE-4A7C-8011-86C3B479FFF7Q52719999-A6E2DBE0-E8A9-4195-9FF8-93AB2E361D8C
P2860
Cisplatin-resistant prostate cancer model: Differences in antioxidant system, apoptosis and cell cycle.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Cisplatin-resistant prostate c ...... tem, apoptosis and cell cycle.
@en
Cisplatin-resistant prostate c ...... tem, apoptosis and cell cycle.
@nl
type
label
Cisplatin-resistant prostate c ...... tem, apoptosis and cell cycle.
@en
Cisplatin-resistant prostate c ...... tem, apoptosis and cell cycle.
@nl
prefLabel
Cisplatin-resistant prostate c ...... tem, apoptosis and cell cycle.
@en
Cisplatin-resistant prostate c ...... tem, apoptosis and cell cycle.
@nl
P2093
P50
P356
P1476
Cisplatin-resistant prostate c ...... stem, apoptosis and cell cycle
@en
P2093
Branislav Ruttkay-Nedecky
Hana Polanska
Jan Balvan
Kristyna Hudcova
Lucia Knopfova
Marketa Sztalmachova
Petr Babula
Veronika Dvorakova
P304
P356
10.3892/IJO.2013.2223
P577
2013-12-20T00:00:00Z